Translartion. Region: Russians Fedetion –
Source: Novosibirsk State University – Novosibirsk State University –
Novosibirsk State University has received a license for a new master’s program “Industrial Pharmacy”, the first intake of students will be in September 2025. This is a network educational program implemented jointly with the Engineering School of Moscow State University, the industrial partners are the companies “Generium”, “Pharmstandard” and “Medico-Biological Union”. This is the first such educational program beyond the Urals. It is planned that up to 20 people will study in the master’s program.
The new master’s program will be implemented on the basis of the infrastructure new campus of NSU, which is being built within the framework of the national project “Youth and Children”. The master’s degree will combine fundamental scientific knowledge concentrated in the Siberian Branch of the Russian Academy of Sciences and the industrial experience of industrial partners. Students will also undergo practical training at Moscow State University and Sechenov University.
— The buildings of the educational and scientific center of the Institute of Medicine and Medical Technologies (IMMT) of NSU and the scientific research center of NSU, which are related to the objects of the second stage of the new campus, will house both educational sites and pilot industrial production in various areas, including pharmaceutical ones, which will allow young specialists to obtain and hone their skills in a licensed production facility located directly at the place of their studies. No university beyond the Urals offers such an opportunity, — commented Mikhail Khvostov, Acting Dean of the Faculty of Pharmacy and Medical Cybernetics of IMMT NSU.
Bachelors of natural science and medical fields will be able to enroll in the master’s program. Within the framework of the program, it will be possible to receive education in two tracks. The first is pharmaceutical development. The educational process will include training in basic, fundamental disciplines, and special courses that provide additional knowledge and develop skills required in scientific research work specifically in pharmacy. The second direction is biotechnology and the production of high-tech drugs, primarily gene therapy and based on human somatic cells. There are only a few such specialists in Russia now.
— There is a major shortage of personnel in the pharmaceutical industry, including research, expert analysis and production. The new master’s program at NSU will allow training professionals in areas that are currently actively developing in our country. Thus, regenerative medicine and health preservation are important elements of the new national project. Therefore, the demand for specialists working in this area will grow every year, — emphasized Mikhail Khvostov.
Master’s students of the new educational program will also participate in the development of products, the creation of which is supported by the Priority 2030 program.
Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.